Headlines

Genmab (GMAB DC/GMAB) 9M 2026 (USD): EBIT 986mln; Operating expenses 2.02bln; Darzalex sales 12.4bln

Newsquawk Staff ·

Genmab (GMAB DC/GMAB) 9M 2026 (USD): EBIT 986mln; Operating expenses 2.02bln; Darzalex sales 12.4bln.

Related headlines